{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:58:19Z","timestamp":1758477499239},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamapediatrics.2018.0733","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T16:46:32Z","timestamp":1525711592000},"page":"701","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy\u2014Reply"],"prefix":"10.1001","volume":"172","author":[{"given":"Vinay","family":"Prasad","sequence":"first","affiliation":[{"name":"Center for Health Care Ethics, Division of Hematology and Medical Oncology, Department of Preventive Medicine and Public Health, Knight Cancer Institute, Oregon Health and Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"plr180006r1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamapediatrics.2017.4360","article-title":"Nusinersen for spinal muscular atrophy: are we paying too much for too little?","volume":"172","author":"Prasad","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"7","key":"plr180006r3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy.","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"plr180006r4","first-page":"471","article-title":"Medical reversal: why we must raise the bar before adopting new technologies.","volume":"84","author":"Prasad","year":"2011","journal-title":"Yale J Biol Med"},{"key":"plr180006r2","unstructured":"US Food and Drug Administration. Medical Review 209531Orig1s000 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000MedR.pdf. Accessed February 26, 2018."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2680048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T19:34:26Z","timestamp":1544124866000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/jamapediatrics.2018.0733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0733","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}